Heart development study in very premature newborns
Part of Heart & circulation clinical trials.
This study examines heart development in babies born extremely early (22-28 weeks) compared to those born closer to full term (34+ weeks). It uses tissue samples from terminated pregnancies to understand how the heart matures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a pregnant woman over 18 years old
- Speak and understand French
- Have scheduled a medically approved abortion at Montpellier University Hospital
- Agree to allow the use of fetal tissue for research
- Not have received betamethasone or dexamethasone in the month before the procedure
- Have no known family genetic mutation linked to heart muscle disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at microscopic particles called extracellular vesicles in the umbilical cord blood of babies born before 28 weeks. Researchers want to see if these particles can help predict severe health problems or death, and eventually improve care for extremely premature newborns.
This study is testing a way to observe and rate the development of very premature babies. It is for babies born between 27 and 32 weeks, in good health, and whose families live near Toulouse.
This study looks at how a mother's mental health during pregnancy may affect the brain development of babies with a serious heart condition called critical cyanotic congenital heart disease (CHD). It aims to understand this link to improve support for families.
This study looks at how a serious heart condition before birth may affect a baby's brain development. It follows babies and their parents to better understand and support these children as they grow.
This study looks at the genetic material in the fluid around the baby (amniotic fluid) and in the placenta to better understand complex heart defects in unborn babies. The goal is to find new clues that could help doctors care for these babies before and after birth.
This study checks unborn babies’ heart signals using special scans during pregnancy and then checks the baby’s heart shortly after birth. It may help researchers understand why certain high-risk pregnancies can lead to fetal demise and improve care.
Hear when a new ELGAN (22-28SA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.